Financial Review: Wuhan General Group (OTCMKTS:WUHN) vs. Graham (NYSE:GHM)

Graham (NYSE:GHM) and Wuhan General Group (OTCMKTS:WUHN) are both industrials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, earnings, dividends, profitability and risk.

Profitability

This table compares Graham and Wuhan General Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Graham	6.28%	13.26%	6.07%
Wuhan General Group	N/A	N/A	N/A

Risk & Volatility

Graham has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Comparatively, Wuhan General Group has a beta of 0.54, suggesting that its share price is 46% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Graham and Wuhan General Group, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Graham	0	3	2	0	2.40
Wuhan General Group	0	0	0	0	0.00

Graham presently has a consensus target price of $72.50, suggesting a potential downside of 9.62%. Given Graham’s stronger consensus rating and higher possible upside, equities analysts plainly believe Graham is more favorable than Wuhan General Group.

Institutional & Insider Ownership

69.5% of Graham shares are held by institutional investors. 6.0% of Graham shares are held by insiders. Comparatively, 61.1% of Wuhan General Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Graham and Wuhan General Group”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Graham	$209.90 million	4.23	$12.23 million	$1.35	59.42
Wuhan General Group	N/A	N/A	N/A	N/A	N/A

Graham has higher revenue and earnings than Wuhan General Group.

Summary

Graham beats Wuhan General Group on 9 of the 10 factors compared between the two stocks.

About Graham

Graham Corporation, together with its subsidiaries, designs and manufactures fluid, power, heat transfer, and vacuum equipment for chemical and petrochemical processing, defense, space, petroleum refining, cryogenic, energy, and other industries. It offers power plant systems, including ejectors and surface condensers; torpedo ejection, propulsion, and power systems, such as turbines, alternators, regulators, pumps, and blowers; and thermal management systems comprising pumps, blowers, and drive electronics for defense sector. The company also provides rocket propulsion systems consisting of turbopumps and fuel pumps; cooling systems, which include pumps, compressors, fans, and blowers; and life support systems that comprise fans, pumps, and blowers for space industry. In addition, it offers heat transfer and vacuum systems, including ejectors, process and surface condensers, liquid ring pumps, heat exchangers, and nozzles; power generation systems, such as turbines, generators, compressors, and pumps; and thermal management systems comprising pumps, blowers, and electronics for energy sector. Further, the company offers heat transfer and vacuum systems consisting of ejectors, process and surface condensers, liquid ring pumps, heat exchangers, and nozzles for chemical and petrochemical processing industry. The company also services and sells spare parts for its equipment. It sells its products directly in the United States, the Middle East, Canada, Asia, South America, and internationally. Graham Corporation was founded in 1936 and is headquartered in Batavia, New York.

About Wuhan General Group

Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.